Skip to content

Analysis of factors affecting medication adherence in schizophrenic patients and study of supportive psychological intervention

Analysis of factors affecting medication adherence in schizophrenic patients and study of supportive psychological intervention

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076924
Enrollment
Unknown
Registered
2023-10-24
Start date
2023-10-30
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Experimental:Supportive psychological interventions
Control:Treat as

Sponsors

Peking University Sixth Hospital, Peking University Institute of Mental Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (i) meet the diagnostic criteria for schizophrenia; (ii) outpatients or inpatients being treated with at least one antipsychotic medication; (iii) have normal intelligence, are capable of completing the assessments, and are able to fully understand the contents of the informed consent form; and (iv) patients whose family members are aware of and agree with the information and voluntarily sign the informed consent form and are willing to cooperate with the study. ? Age 18-60 years old.

Exclusion criteria

Exclusion criteria: Patients who are in the acute phase of schizophrenia; ? patients with other mental illnesses or alcohol or drug dependence, or patients with traumatic brain injury, epilepsy, or serious heart, liver or kidney disease; ? patients who are intellectually challenged or unable to cooperate with the study for other reasons; ? patients who have been treated with long-acting antipsychotics in the past 90 days; ? patients who have received other cognitive-behavioral treatments in the past 90 days; ? females who are pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
The Morisky Medication Adherence Scale;

Secondary

MeasureTime frame
Positive and Negative Syndrome Scale;Schizophrenia Quality of Life Scale for Patients with Schizophrenia (SQLS);Self-Awareness and Treatment Attitudes Questionnaire;

Countries

China

Contacts

Public ContactWeihua Yue

The Sixth Hospital / Institute of Mental Health Peking University

dryue@bjmu.edu.cn+86 10 8280 5307

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026